Pfizer Defends Claims Against Parkinson’s Disease Drug in Bellwether MDL

In its first and only bellwether MDL trial, Pfizer defended claims made by plaintiffs that they failed to warn of the side effects of their drug for Parkinson’s disease. Our firm served as MDL liaison, co-trial and local counsel in Minnesota for the trial. Charbonneau v. Pfizer, Inc. et. al, No. 06-CV-1215, U.S. District Court, District of Minnesota.